Opicapone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Opicapone. Educational only — not medical advice.
Labeled uses
ONGENTYS is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.
Source: FDA labeling via NIH DailyMed (set a511a531…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.